Integrated analysis of single-cell and bulk RNA sequencing identifies GSTM4 as a tumor suppressor and prognostic biomarker in breast cancer
Integrated analyses identify GSTM4 as a potential tumor suppressor and prognostic biomarker in BC, suggesting its promise for advancing therapies.
Authors
- Weikang Yun
- Xu Liu (ORCID: https://orcid.org/0000-0002-3956-946X)
- Zhen Yu (ORCID: https://orcid.org/0000-0002-1836-4350)
- Qian Zhang (ORCID: https://orcid.org/0000-0003-4434-8773)
- Xianglan Li
- Chunbo Zhao (ORCID: https://orcid.org/0000-0003-0820-9960)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s12672-025-03850-z
- Primary Topic
- Genomics and Chromatin Dynamics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation